Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother's risk of delivering spontaneously. It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Metric	Value
Current Market Cap	$139.69M
Last Price	$1.75
52-Week High	$4.09
52-Week Low	$1.56

	A	B	C	D
1	Symbol	Price	Change	Volume
2	SERA	$1.75	-7.41%	0.09M
3
4
5

Sera Prognostics Inc. (SERA) Market Capitalization

Market Cap Data

Get Sera Prognostics Inc. Data in Excel

More SERA Financial Data